EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTION

巨细胞病毒感染的外转录调控

基本信息

项目摘要

7. PROJECT SUMMARY / ABSTRACT Chemical modification of mRNA provides a powerful means to dynamically alter gene expression in eukaryotes via epitranscriptomic changes. In particular, methylation of adenosine at the N6 position (m6A) constitutes the most widespread internal base modification to mRNA. Modification of mRNA by m6A influences numerous biological processes including development, differentiation, reprogramming, circadian rhythm, cell cycle, disease pathogenesis, and stress responses including virus infection. Significantly, virus-encoded mRNAs are also chemically modified by m6A, and a role for m6A in Human Cytomegalovirus (HCMV) infection biology is emerging. As a canonical TORCH (T. gondii, other, rubella virus, HCMV, HSV) pathogen, primary HCMV infection during pregnancy remains the leading viral cause of birth defects. While HCMV infection causes mild if any maternal morbidity and is predominately asymptomatic in healthy individuals, it results in life-threatening disease among the immunocompromised, including solid-organ or stem cell transplant recipients, and is a significant source of congenital morbidity and mortality among newborn infants in the developed world. Addressing HCMV congenital infection remains a serious unmet medical need as there is no HCMV vaccine to prevent primary infection during pregnancy and no current treatment to prevent transmission from mother to fetus. Our long-term objective is to understand how the chemical modification of host and/or viral RNA by m6A impacts reproduction of HCMV, a common infection that remains the leading viral cause of congenital abnormalities. Preliminary results demonstrate that cellular m6A methyltransferase subunits METTL3/14, the m6A demethylase ALKBH5, and m6A recognition proteins regulate HCMV reproduction and responses to double strand DNA (dsDNA) in uninfected cells. This is achieved in part through changes in interferon b gene (IFNB1) expression. These findings establish that m6A RNA modification enzymes regulate cellular responses to HCMV and dsDNA sensing, which shapes host immunity and contributes to autoimmune disease. It further suggests that m6A epitranscriptomic changes play a fundamental role in cell-intrinsic innate immune responses to the TORCH pathogen HCMV. Based upon our preliminary results, we hypothesize that HCMV reproduction is differentially controlled by the host m6A modification machinery. Here, this hypothesis will be tested in three specific aims designed to: (i) identify how the host m6A modification machinery is regulated in response to HCMV infection; (ii) determine how cellular m6A modification enzymes regulate IFNB1 mRNA accumulation in HCMV-infected cells; and (iii) identify how HCMV gene expression is impacted by differential m6A modification. The project is significant because it investigates how epitranscriptomic changes impact HCMV reproduction and innate immunity. Understanding how HCMV infection is regulated by epitranscriptomic RNA modification could lead to new opportunities for therapeutic intervention and possibly new strategies for vaccine development.
7.项目总结/摘要 mRNA的化学修饰为动态改变真核生物基因表达提供了强有力的手段 通过epitranscriptomic变化。特别是,N6位置(m6 A)的腺苷甲基化构成了 最广泛的内部碱基修饰的mRNA。m6 A对mRNA的修饰影响了许多 生物过程包括发育、分化、重编程、昼夜节律、细胞周期, 疾病发病机制和包括病毒感染在内的应激反应。值得注意的是,病毒编码的mRNA 也被m6 A化学修饰,并且m6 A在人巨细胞病毒(HCMV)感染生物学中的作用是 正在浮现作为一个典型的火炬(T。弓形虫,其他,风疹病毒,HCMV,HSV)病原体,原发性HCMV 怀孕期间的感染仍然是导致出生缺陷的主要病毒原因。虽然HCMV感染导致轻度 如果有任何母体发病,并且在健康个体中主要是无症状的,则会导致危及生命的 疾病的免疫功能低下,包括实体器官或干细胞移植受体,是一种 这是发达国家新生儿先天性发病率和死亡率的重要来源。 解决HCMV先天性感染仍然是一个严重的未满足的医疗需求,因为没有HCMV疫苗, 预防怀孕期间的原发感染,目前没有预防母婴传播的治疗方法。 胎儿我们的长期目标是了解宿主和/或病毒RNA的化学修饰是如何 m6 A影响HCMV的繁殖,HCMV是一种常见的感染,仍然是导致人类免疫缺陷病毒的主要病毒原因。 先天性畸形初步结果表明,细胞m6 A甲基转移酶亚基 胃L3/14、m6 A去甲基化酶ALKBH 5和m6 A识别蛋白调节HCMV繁殖, 在未感染的细胞中对双链DNA(dsDNA)的反应。这部分是通过改变 干扰素B 1基因表达。这些发现证实了m6 A RNA修饰酶调节 细胞对HCMV和dsDNA传感的反应,其形成宿主免疫并有助于自身免疫性 疾病它进一步表明,m6 A表观转录组的变化在细胞内在的先天性免疫应答中起着重要作用。 对TORCH病原体HCMV的免疫应答。根据我们的初步结果,我们假设, HCMV复制受宿主m6 A修饰机制的差异控制。这个假设 将在三个具体目标进行测试,旨在:(i)确定主机m6 a改装机械如何 调节响应HCMV感染;(ii)确定细胞m6 A修饰酶如何调节IFNB 1 在HCMV感染的细胞中的mRNA积累;和(iii)鉴定HCMV基因表达如何受到 差异化m6 A修饰。该项目是重要的,因为它调查如何epitranscriptomic变化 影响HCMV繁殖和先天免疫。了解HCMV感染是如何通过 表转录组RNA修饰可能为治疗干预带来新的机会, 疫苗开发的新策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Pearce Depledge其他文献

Daniel Pearce Depledge的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Pearce Depledge', 18)}}的其他基金

EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTION
巨细胞病毒感染的外转录调控
  • 批准号:
    10578844
  • 财政年份:
    2020
  • 资助金额:
    $ 56.24万
  • 项目类别:

相似国自然基金

细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
  • 批准号:
    81570244
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
  • 批准号:
    81171113
  • 批准年份:
    2011
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
  • 批准号:
    10929664
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
Exploring the role of adenosine A2A receptors in Schizophrenia using opto-pharmacologically controlled allosteric modulation.
利用光药理学控制的变构调节探索腺苷 A2A 受体在精神分裂症中的作用。
  • 批准号:
    23K14685
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Role of Adenosine Kinase in Mixed Diastolic Heart Failure and Alzheimer Disease
腺苷激酶在混合性舒张性心力衰竭和阿尔茨海默病中的作用
  • 批准号:
    10679989
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
  • 批准号:
    BB/W016974/1
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
    Research Grant
Investigation of new test methods for adenosine-sensitive atrioventricular block
腺苷敏感型房室传导阻滞新检测方法的探讨
  • 批准号:
    23K07566
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing the role of adenosine pathway in SIV pathogenesis
探讨腺苷途径在 SIV 发病机制中的作用
  • 批准号:
    10760676
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
The role of A1 adenosine receptor signaling in the decline of S. pneumoniae killing by neutrophils in vaccinated aged hosts
A1 腺苷受体信号传导在疫苗接种老年宿主中中性粒细胞杀伤肺炎链球菌下降中的作用
  • 批准号:
    10605737
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
Adenosine triphosphate as a master variable for biomass in the oceanographic context
三磷酸腺苷作为海洋学背景下生物量的主变量
  • 批准号:
    2319114
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
    Standard Grant
Late-Stage Functionalisation of Cyclic Guanosine Monophosphate - Adenosine Monophosphate
环单磷酸鸟苷-单磷酸腺苷的后期功能化
  • 批准号:
    2751533
  • 财政年份:
    2022
  • 资助金额:
    $ 56.24万
  • 项目类别:
    Studentship
Postnatal development of adenosine kinase in the brainstem network that controls breathing
控制呼吸的脑干网络中腺苷激酶的出生后发育
  • 批准号:
    573323-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 56.24万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了